Member login

Forgot Password?

By using the members area you have already agreed to share your personal information with the BBA so that you can access the members materials. We will store your details only as long as you are a member. Your personal information will not be shared any affiliated companies or third parties. For more information about our Privacy Policy, click here.

Return to login



03.04.2019 British Biosimilars Association (BBA) appoints new vice-chair 23.11.2018 New voluntary scheme for Branded Medicines Pricing and Access 15.10.2018 Adalumimab launches 24.09.2018 FMD safety feature consultation response 24.08.2018 No-deal Brexit technical notices and reference products 23.08.2018 Response to government’s publication of technical notices on plans to regulate medicines in the event of a no-deal Brexit 23.08.2018 Response to the Secretary of State for Health’s letter to medicines Marketing Authorisation Holders 07.08.2018 Reaction to the Government’s publication of a consultation on changes to the statutory medicines pricing scheme 31.07.2018 Director General of the British Generic Manufacturers Association (BGMA) and British Biosimilars Association (BBA) Warwick Smith’s reaction to NHS Improvements study on the savings delivered from 10 medicines which have switched to generics or biosimilars 14.12.2017 BREXIT Life Science Coalition Joint position paper media release 14.12.2017 UK Exiting from EU Life Science industry coalition position paper 27.11.2017 Reaction to the Government’s Industrial Strategy White Paper 15.11.2017 British Biosimilars Association (BBA) appoints new chair 10.10.2017 Response to the publication the Care Quality Commission’s annual State of Care report 12.09.2017 Reaction from the British Biosimilars Association (BBA) to NHS England’s Simon Stevens speech at the Expo conference in Manchester. 31.08.2017 BGMA Statement on Sir John Bell's Life Sciences Industrial Strategy 18.04.2016 British Biosimilars Association (BBA) launches in UK